Abstract: A National Project for the in-vivo dosimetry in radiotherapy: first results

Similar documents
brochure DISO fronte.jpg Locandina commerciale

Breast in vivo dosimetry by EPID

Are Transmission Detectors a Necessary Tool for a Safe Patient Radiation Therapy Program?

Leila E. A. Nichol Royal Surrey County Hospital

Intensity Modulated Radiation Therapy: Dosimetric Aspects & Commissioning Strategies

Evaluation of Dosimetry Check software for IMRT patient-specific quality assurance

EORTC Member Facility Questionnaire

D DAVID PUBLISHING. Uncertainties of in vivo Dosimetry Using Semiconductors. I. Introduction. 2. Methodology

S. Derreumaux (IRSN) Accidents in radiation therapy in France: causes, consequences and lessons learned

DOSIMETRIC COMPARISION FOR RADIATION QUALITY IN HIGH ENERGY PHOTON BEAMS

Portal dosimetry in wedged beams

Quality assurance in external radiotherapy

IMRT point dose measurements with a diamond detector

Disclosure. Outline. Machine Overview. I have received honoraria from Accuray in the past. I have had travel expenses paid by Accuray in the past.

Dosisverifikation mit Delta 4 Discover während der Behandlung

IMRT QA: Point Dose Measurements or 2D Array?

IVD TIMING test 1 test at 1 fraction 2 test at 2 fraction 3 test at 3 fraction 4 test during next week 5 test during next week 6 test during next week

Spatially Fractionated Radiation Therapy: GRID Sponsored by.decimal Friday, August 22, Pamela Myers, Ph.D.

Small field diode dosimetry

Additional Questions for Review 2D & 3D

An Independent Audit and Analysis of Small Field Dosimetry Quality Assurance. David Followill IROC Houston QA Center

PGY-1. Resident Review Session Schedule

Can we hit the target? Can we put the dose where we want it? Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy

SunCHECK Patient Comprehensive Patient QA

A comparative study between flattening filter-free beams and flattening filter beams in radiotherapy treatment

CHAPTER 5. STUDY OF ANGULAR RESPONSE OF asi 1000 EPID AND IMATRIXX 2-D ARRAY SYSTEM FOR IMRT PATIENT SPECIFIC QA

Data Collected During Audits for Clinical Trials. July 21, 2010 Geoffrey S. Ibbott, Ph.D. and RPC Staff

Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT

Verification of treatment planning system parameters in tomotherapy using EBT Radiochromic Film

Varian Treatment. Streamlined Treatment Delivery Management Application. Specifications

Limits of Precision and Accuracy of Radiation Delivery Systems

CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT

Dosimetric study of 2D ion chamber array matrix for the modern radiotherapy treatment verification

RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident

A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *

IGRT1 technologies. Paweł Kukołowicz Warsaw, Poland

IMRT QUESTIONNAIRE. Address: Physicist: Research Associate: Dosimetrist: Responsible Radiation Oncologist(s)

Eric E. Klein, Ph.D. Chair of TG-142

The RPC s Evaluation of Advanced Technologies. AAPM Refresher Course July 29, 2008 Geoffrey S. Ibbott, Ph.D. and RPC Staff

I. Equipments for external beam radiotherapy

INTRODUCTION. Material and Methods

Assessment of Dosimetric Functions of An Equinox 100 Telecobalt Machine

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan

Imaging of Scattered Radiation for Real Time Tracking of Tumor Motion During Lung SBRT

Dose rate response of Digital Megavolt Imager detector for flattening filter-free beams

6/29/2012 WHAT IS IN THIS PRESENTATION? MANAGEMENT OF PRIMARY DEVICES INVESTIGATED MAJOR ISSUES WITH CARDIAC DEVICES AND FROM MED PHYS LISTSERVS

Plan-Specific Correction Factors for Small- Volume Ion Chamber Dosimetry in Modulated Treatments on a Varian Trilogy

To Reduce Hot Dose Spots in Craniospinal Irradiation: An IMRT Approach with Matching Beam Divergence

Use of Electronic Portal Image Detectors for Quality Assurance of Advanced Treatments

Pre-treatment and in-vivo dosimetry of Helical Tomotherapy treatment plans using the Dosimetry Check system

Reference Photon Dosimetry Data for the Siemens Primus Linear Accelerator: Preliminary Results for Depth Dose and Output Factor

Feasibility of portal dosimetry for flattening filter-free radiotherapy

Volumetric Modulated Arc Therapy - Patient Specific QA

SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES

Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact. Stephen F. Kry, Ph.D., D.ABR.

Follow this and additional works at:

IROC Prostate Phantom. Guidelines for Planning and Treating the IROC IMRT Prostate Phantom. Revised March 2014

Future upcoming technologies and what audit needs to address

The Physics of Oesophageal Cancer Radiotherapy

MAESTRO: Methods and Advanced Equipment for Simulation and Treatment in Radiation Oncology

An anthropomorphic head phantom with a BANG polymer gel insert for dosimetric evaluation of IMRT treatment delivery

Verification of Relative Output Factor (ROF) Measurement for Radiosurgery Small Photon Beams

Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 4, NUMBER 4, FALL 2003

THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

Implementing New Technologies for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments

What Can Go Wrong in Radiation Treatment: Data from the RPC. Geoffrey S. Ibbott, Ph.D. and RPC Staff

Amendment No. 2. Item No. 2 (Rfx/ Event number )

Prostate Phantom. Guidelines for Planning and Treating the IMRT Prostate Phantom. Revised March 2014

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

EPID dosimetry for pretreatment quality assurance with two commercial systems

Patient and Linac QA - present and the future

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017

8/2/2017. Objectives. Disclosures. Clinical Implementation of an MR-Guided Treatment Unit

Technical Study. Institution University of Texas Health San Antonio. Location San Antonio, Texas. Medical Staff. Daniel Saenz. Niko Papanikolaou.

IROC Head and Neck Phantom. Guidelines for Planning and Irradiating the IROC IMRT Phantom. Revised MARCH 2014

Assessment of variation of wedge factor with depth, field size and SSD for Neptun 10PC Linac in Mashhad Imam Reza Hospital

IROC Liver Phantom. Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015

MEDICAL PHYSICS INTERNATIONAL Journal, vol.3, No.2, 2015 HOW TO

Calibration of dosimeters for small mega voltage photon fields at ARPANSA

Implementation of advanced RT Techniques

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

International Practice Accreditation

IN VIVO DOSIMETRY MEASUREMENTS FOR BREAST RADIATION TREATMENTS

Collapsed Cone Convolution 2D illustration

Quality assurance of volumetric modulated arc therapy using Elekta Synergy

Verification of Advanced Radiotherapy Techniques

A TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM *

Borges C 1, Zarza- Moreno M 2, Teixeira N 2, Vaz P 3 1

Standardization of dosimetry practices for small and large animal irradiation in radiobiological studies

Feasibility study on the verification of actual beam delivery in a treatment room using EPID transit dosimetry

The Journey of Cyberknife Commissioning

VMAT plans for treatment prostate cancer: Dosimetric verifications and comparison with 3D-CRT and IMRT

Introduction. Measurement of Secondary Radiation for Electron and Proton Accelerators. Introduction - Photons. Introduction - Neutrons.

LONG TERM STABILITY OF THE PERFORMANCE OF A CLINICAL LINEAR ACCELERATOR AND Z-SCORE ASSESSEMENT FOR ABSORBED DOSE TO WATER QUANTITY

3D Conformal Radiation Therapy for Mucinous Carcinoma of the Breast

ARCCHECK: COMPREHENSIVE EVALUATION OF THE DIODE ARRAY PHANTOM - RULES OF THUMB FOR PHANTOM USE FOR QA. By Vibha Chaswal, Ph.D.

Evaluation of Dynamic Delivery Quality Assurance Process for Internal Target Volume Based RapidArc

Transcription:

Abstract: A National Project for the in-vivo dosimetry in radiotherapy: first results A.Piermattei 1, L. Azario 1, S. Cilla 2, A.Fidanzio 1, F.Greco 1, M.T.Russo 3, S. Zucca 4 1 Istituto di Fisica e Unità Operativa di Fisica Sanitaria, Università Cattolica del S. Cuore, Roma 2 Unità Operativa di Fisica Sanitaria, Fondazione per la Ricerca e Cura Giovanni Paolo II, Campobasso 3 Unità Operative di Radioterapia e Fisica Sanitaria, Ospedale Belcolle, Viterbo 4 Unità Operativa di Fisica Sanitaria, Presidio Oncologico Businco, Cagliari The work reports the first results of a National Project financed by the National Institute of Nuclear Physics for the development of in-vivo dosimetric procedures in radiotherapy. The first objective has been the development of a generalized procedure for the in-vivo dose reconstruction at the isocenter point, D iso, for 3D conformal radiotherapy treatments, with open and wedged x-ray beams supplied by linacs of different manufacturers and equipped with asi EPID. This way the commissioning procedure is greatly simplified and applicable at Elekta, Siemens and Varian linacs and the results of the in-vivo tests are reported in quasi-real time. The method is based on two calibration procedures for x-ray beams and asi EPIDs. In particular, generalized mid-plane doses in solid water phantom D 0, and transit signal s 0 t values were obtained by 19 open and 38 wedged beams of 8 different linacs. Generalized ratios F = s t / D were fitted by surface equations and together with other parameters were used by the algorithm to convert the integral transit signals S t, in reconstructed doses D iso, to compare with the D iso,tps (computed by the TPS) using a tolerance level of 5% for pelvic, breast, head tumors and lung cancer treatments. Moreover the dedicated software supplied for each beam, the γ-analysis for a 2D comparison between portal images, using alert criteria γ mean >0.5 and P γ >1 >10%. The generalized in-vivo dosimetry procedure has been adopted by 8 centers that used different linacs. The results of about 5000 tests showed that about 85% of the tests were well-within tolerance levels. The dose discrepancies were due to patient's set-up misalignment, presence of attenuating media in the field, patient's morphological changes, no correct wedge TPS implementation, no correct CT number calibration, dose output variations, and CT simulator laser misalignments. The results were supplied in quasi-real time because the dedicated software used the information of the 'record and verify' network of the centers. Consequently, the extra-time needed to obtain the results after the dose delivery was about 20 seconds per beam. At present, the second objective of the National Project is the application of the same method at IMRT beams. The same algorithm developed for open beams can be utilized for the IMRT step-shoot and slidewindow beams, adopting corrections that take into account (i) the effect of the radiation transmitted through the MLC on the integral signal S t and (ii) the effect of the fluence inhomogeneity on the generalized ratios F 0. However, the preliminary in-vivo results obtained for step-shoot and slide-window IMRT with different linacs confirm that it is possible (i) to reduce strongly the commissioning time and (ii) to obtain in a quasi-real time the results of tests. The success of this step could encourage future developments of the project for modulated arc-radiotherapy in-vivo dosimetry.

Contributo orale

Stand Best Medical International

Area poster

In-vivo dose reconstruction for tangential treatments of breast cancer : a generalized procedure F. Greco1, L. Azario1, A. Fidanzio1, S. Cilla2, M. Russo3, S. Zucca4, L. C. Orlandini5, M. Betti5, A. Piermattei1 1Istituto di Fisica e Unità Operativa di Fisica Sanitaria, Università Cattolica del S. Cuore, Roma 2Unità Operativa di Fisica Sanitaria, Fondazione per la Ricerca e Cura Giovanni Paolo II, Campobasso 3Unità Operativa di Radioterapia, Ospedale Belcolle, Viterbo 4Unità Operativa di Fisica Sanitaria, Presidio Oncologico Businco, Cagliari 5Unità Operativa di Fisica Medica, Centro Oncologico Fiorentino, Firenze Introduction The work is part of a National Project financed by the National Institute of Nuclear Physics for the development of in-vivo dosimetric procedures in radiotherapy. In particular the work reports a practical and accurate generalized procedure for linacs Varian, Elekta and Siemens, equipped with asi Electronic Portal Imaging Devices (asi EPIDs) for in-vivo dose reconstruction at breast mid-thickness in tangential x-ray treatments carried out by physical and virtual wedge. The generalized procedure is easily commissioned, due to the strong reduction of the time required by implementation measurements. Moreover a dedicated software, that can collect informations from the Record & Verify (R&V) network of the centres, supplies the in-vivo results in quasi-real time. This last objective is particularly recommended for this kind of quality control in radiotherapy. The authors are now developing a new generation software in cooperation with Best Medical Italy, to be commercialized. Materials and methods Transit dosimetry method The method is based on correlation ratios between the EPID transit signals and the doses at mid-thickness measured along the chords, w, of cylindrical water phantoms (CWP) [1]. An ion-chamber (0.125 cm3 in volume, PTW Freiburg) was positioned at the Source to Axis Distance (SAD), along the beam central axis to determine the dose values, Dm, at the mid-thickness of the chord (fig.1). For the transit signal, st, measurements the EPID was positioned at Source-EPID-Distance (SED) equal to 159 cm. In order to generalized the method, two calibration factors have been adopted. The first one, k0, takes into account the x-ray beam output and is defined by 1cGy/ UM k0 = DSAD,w The software is able to supply the result after the therapy session assuring a quasirealtime in-vivo dosimetry (IVD) (fig.2). (1) where DSAD,w is the dose in water phantom at the depth of 10 cm, SSD=90 cm, for wedged beam 10 10 cm2. This way the doses, Dm, were normalized by the respective factor k0, obtaining a set of generalized doses, D0, that were independent of the MU calibration adopted by the center [3]. The second factor, ks, takes into account the EPID sensitivity and is defined by 1cCU / UM ks = sr,t (2) where sr,t, is a reference signal obtained irradiating a standard solid water phantom 22 cm thick for a 10 10 cm2 wedged beam. The transit signals, st, by different asi EPIDs, were multiplied by the ks, obtaining a set of generalized transit signals, s0, that were independent both from MU calibration and asi EPID sensitivity [3]. The correlation ratios, s0/d0, were fitted by linear function as follows 0 F (WAF, w) A(w) WAF B(w) (3) where the parameters A(w) and B(w) were polynomial functions of w and WAF is the wedge attenuation factor defined in previous paper[2].the reconstructed dose, Dm,R, at the breast mid-thickness for a tangential beam is obtained by D m,r ks St k0 (4) f (d) 0 F (WAF, w) SAD d SAD 2 where St is the EPID integral signal corrected by the factor ks and the factor k0; d is the distance between midthickness and the isocenter point; F0 is the correlation function defined by equation 3; and the function f(d) takes into account the scatter contribution on the EPID. Figure 2. Immediately after the therapy session a radiology technician can visualize on a monitor (on the right) the dose obtained by the IVD method. Results 900 tests were carried out in three centers that used different linacs. In particular 300 tests were performed by Varian linacs with physical wedges, 300 tests by Elekta linacs with physical wedges and 300 tests by Siemens linacs with virtual wedges. The R values resulted well-within the tolerance level in 93% of tests. The remaining 7% of the tests, outside the tolerance level, were due to incorrect set-up of patient (5%), output factor variation (1%), wing board attenuation (1%). Figure 3 shows the results of the IVD for a single patient as displayed on the computer screen. The figure 3a shows the CT scan and the beam geometrical edges for beam at 53. Figure 3b shows two transit signals profiles obtained at the beginning of the treatment and after three fractions, respectively. The second profile shows a loss of patient set-up (shift of the beam inner edge towards the chest wall), responsible of an increase of the radiological thickness, w, and R equal to 0.90. In this case the MPI was not carried out before the irradiation. Figure 3c reports the R values resulted in five checks both the tangential beams. 53 a) a) Figure 1. Experimental set-up Software A dedicated software was developed for dose reconstruction using the informations stored in R&V system. The software can be configured by users introducing the factors WAF, k0, ks and was developed in two modules. The first one was developed for a pre-treatment step that uses the Digital Imaging and COmmunications in Medicine (DICOM) files supplied by the CT scanner and the Treatment Planning System (TPS). The patient CT scan is used to determine the water-equivalent thicknesses, w; the DICOM files from TPS, for every tangential beam, supplied the dose at mid-thickness computed by TPS, Dm,TPS. The second module was developed for the post-treatment step. The DICOM files from EPID, obtained for each beam, after the patient daily treatment, supplies the integral signal St to be used in equation 4 for the dose reconstruction Dm,R. For every beam, the software supplies the comparison between the Dm,R and Dm,TPS in terms of R values. The tolerance level of the R values was estimated in 5%. Moreover, the software supplies transit signal profiles crossing the beam central axis to help to investigate the causes of the possible dose variations. (1) A. Fidanzio, F. Greco, A. Mameli, L. Azario, M. Balducci, M. A. Gambacorta, V. Frascino, S. Cilla, D.Sabatino, A. Piermattei, Breast in vivo dosimetry by EPID, Journal of Applied Clinical Medical Physics 11 (2010) 249-262. (2) A.Piermattei, F. Greco, L.Azario, A. Porcelli, S. Cilla, D. Sabatino, A. Russo, G. D Onofrio, M. Russo, A. Fidanzio, Real time dose reconstruction for wedged photon beams: a generalized procedure, JACMP 12(4) (2011) 124-138. (3) A.Piermattei, F.Greco, L.Azario, A.Porcelli, S.Cilla, S.Zucca, A.Russo, E.D.Castro, M.Russo, R.Caivano, V.Fusco, A.Morganti, A.Fidanzio, A National Project for in-vivo dosimetry procedures in radiotherapy: first results, NIM B 274 (2012) 42-50. Figure 3 a) The patient CT scan crossed by the beam central axis (dashed line) at 53 and the beam geometrical boundaries (continuous lines); b) Signal EPID profiles obtained for the beam at 53, at the beginning of the treatment (heavy line) and at second therapy fraction (thin-line). c) Diagram of five R ratios obtained for the two tangential beams at 53 ( ) and 133 ( ). Conclusion The IVD method here reported avoids the measurements in CWP and it can be easily included in the Quality Assurance program of the center. Moreover the use of the dedicated software supplied the dosimetric results in quasi real-time as urged by recent recommendations. At the moment, the objective of the National Project is the application of the IVD method at IMRT and arcradiotherapy treatments.